Blistex launches new lip balms
OAK BROOK, Ill. — Blistex expanded its product portfolio in October with the launch of two new lip balms — Nurture and Nourish and Lip Vibrance.
Blistex Nurture and Nourish goes beyond protection and hydration to feed lips from the inside out with a vitamin/mineral/nutrient-rich formula. Ingredients include Gogi extract, which is high in antioxidants that help neutralize skin damage; copper and zinc, which helps to improve skin elasticity; and vitamin E , which soothes dry, rough skin.
Blistex Nurture and Nourish, which has SPF 15 sun protection, retail for between $1.59 and $2.49.
Blistex has married color and care with its new Blistex Lip Vibrance. The balm provides a noticeable but subtle amount of color and shimmer plus moisturization and protection with a combination of natural emollients and antioxidants, including grapeseed oil, shea butter and vitamin E.
Blistex has created a proprietary pigment blend that provides a broadly appealing shade of red. It also provides a distinct but subtle shimmer that complements its hue. The formula contains micronized cosmetic-grade pigment in a wear-resistant base that provides a longer lasting effect than typical for a tinted lip balm, the company stated.
Blistex Lip Vibrance comes in a lipstick-type container that features a built-in mirror on the cap to allow for better control when applying. The retail prices ranges between $1.99 and $3.29.
No comments found
Pure Encapsulations launches new probiotic product
SUDBURY, Mass. — Pure Encapsulations on Thursday introduced PureHeart Probiotic, the newest addition to the PureHeart Protocol: Screening + Supplements = Success line of nutritional supplements.
“With the proprietary probiotic strain Lactobacillus reuteri NCIMB 30242, PureHeart Probiotic offers evidence-based support from a new angle in clinical cardiology,” stated Kelly Heim, nutritional pharmacologist at Pure Encapsulations. “This exclusive formulation addresses basic aspects of lipid metabolism and vascular function.”
Micropharma, the supplier of Lactobacillus reuteri NCIMB 30242, is a Canadian biotechnology company focused on human metabolic health through the microbiome.
Special features of PureHeart Probiotic also include its shelf-stable formulation and acid-resistant capsules. These features allow for maintained viability without refrigeration and maximum probiotic delivery to the G.I. tract. Since the strain is grown on a dairy-free, soy-free medium, it is suitable for individuals with sensitive or restrictive diets, the company stated.
Awesome company to work and purchase product from. I have used them for many years in my practice with excellent results. Their quality control with clinical trials is unmatched...
Boiron launches Children’s Chestal Cold & Cough
NEWTON SQUARE, Pa. — Boiron on Thursday introduced a new pediatric cough-cold item to its lineup — Children’s Chestal Cold & Cough, a multi-symptom formula. The new syrup targets such symptoms of the common cold as nasal and chest congestion, cough, runny or stuffy nose, sneezing and minor sore throat. It provides parents with an option that works naturally with their little one’s bodies for children ages 3 years and older after manufacturers of antihistamines and decongestants relabeled their products for children 4 years of age and older.
Like Boiron’s other Chestal formula, this latest addition works to improve the productivity of all types of common coughs. The syrup coats and soothes little throats, and the blend of homeopathic medicines loosens chest congestion, thereby making common coughs more productive for a speedier recovery. This formula also targets a cough with thick phlegm associated with nasal congestion.
Additionally, Children’s Chestal Cold & Cough does not cause drowsiness or interact with other medications.
The most popular member of the Chestal all-star lineup is Children’s Chestal 4.2 fl oz., Boiron reported. According to Boiron, over the 52-week period ending July 14, this SKU grew more than twice as much (14.5%) than the cough, cold and flu products category at the largest drug retailer (7.1%).
No comments found